eFLASH for Skin Lesions of Malignant Melanomas

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

May 27, 2025

Study Completion Date

July 31, 2026

Conditions
Metastatic Melanoma
Interventions
RADIATION

Electron FLASH radiotherapy

A nominal electron energy of 9 MeV will be used for both Flash-RT and Conv-RT, which guarantees ≥ 90% dose coverage up to a depth of 2.8 cm. Shallower lesions will be treated with the same electron energy and with a bolus. In order to treat these patients, field sizes between 2x2cm2 and 10x10cm2 will be used, which can be delivered with sufficient flatness (\<5%) and symmetry (\<2%) by the FlashTrueBeam v2.7.5.

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
collaborator

Varian, a Siemens Healthineers Company

INDUSTRY

lead

University of Zurich

OTHER

NCT06549439 - eFLASH for Skin Lesions of Malignant Melanomas | Biotech Hunter | Biotech Hunter